drugset / Trial / NCT04975334
Opioid Antagonism in Hypogonadotropic Hypogonadism
NaSingle-groupOpen-labelOther
Summary
The goal of this study is to evaluate the effects of opioid antagonists on the hypothalamic-pituitary-gonadal axis in subjects with hypogonadotropic hypogonadism (HH).
Timeline
- Start
- 2025-06-18
- Primary completion
- 2025-09-26
- Completion
- 2025-09-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Naloxone | Small molecule | — | Intravenous |